1460 Journal of Natural Products, 2008, Vol. 71, No. 8
Notes
broth extract (1.5 g), which was subjected to Si gel flash chromatog-
raphy. Elution was performed with n-hexane-EtOAc (stepwise,
0-100% EtOAc) to yield four fractions. Fractions 3 and 4 were
separated by medium-pressure liquid chromatography (MPLC) (ODS)
using a H2O-MeOH gradient elution to afford crude compounds 3-5
and 1/2, respectively. These were further purified by HPLC (YMC,
ODS-A) utilizing a 30 min gradient program of 50% to 100% MeOH
in H2O to furnish 1 (5.2 mg), 2 (5.4 mg), 3 (60 mg), 4 (70 mg), and 5
(80 mg), respectively.
(8S,9S)-8-chloro-9-hydroxy-8,9-deoxyaspyrone (1a, 1.0 mg). The latter
was dissolved in MeOH (1 mL), and an aliquot (10 µL) of the sample
solution was analyzed by HPLC [Alltech, Apollo C18, 10 × 250 mm,
MeOH-H2O, 2:3, UV detector (254 nm)] (see Figure S1 in the
Supporting Information).
(8S,9S)-8-Chloro-9-hydroxy-8,9-deoxyaspyrone (1a): 1H NMR
(DMSO-d6, 400 MHz) δ 7.02 (1H, d, J ) 2.7 Hz, H-4), 4.18 (1H, m,
H-5), 4.23 (1H, m, H-6), 1.32 (3H, d, J ) 6.5 Hz, H3-7), 4.66 (1H, d,
J ) 4.3 Hz, H-8), 4.00 (1H, ddq, J ) 6.5, 5.9, 4.3 Hz, H-9), 1.12 (3H,
d, J ) 5.9 Hz, H3-10), 5.88 (1H, d, J ) 5.9 Hz, 5-OH), 5.06 (1H, d,
J ) 5.9 Hz, 9-OH).
Chlorohydroaspyrone A (1): colorless oil; [R]2D0 -110 (c 0.1,
MeOH); UV (MeOH) λmax (log ε) 272 (4.10); IR (neat) νmax 3344,
1
2980, 1709, 1639, 1448, 1379, 1219, 1144, 1060 cm-1; H and 13C
Antibacterial Assay. The in Vitro antibacterial activity of the
fermentation broth and purified samples was evaluated by a conven-
tional 2-fold serial dilution method using S. aureus, methicillin-resistant
S. aureus, and multidrug-resistant S. aureus as indicator strains. A 5
mL suspension containing 105 cells per mL was used as inoculum of
the test organism. The MIC values were determined after the inoculation
for 18 h at 37 °C.2
NMR, see Table 1; EIMS 223 [M (37Cl) + 1]+ (0.18), 221 [M (35Cl)
+ 1]+ (0.5), 203 [(M + 1) - H2O]+ (0.3), 178 [M (37Cl) - CH3CHO]+
(4.4), 176 [M (35Cl) - CH3CHO]+ (15), 160 [176 (37Cl) - H2O]+ (12),
158 [176 (35Cl) - H2O]+ (37), 141 (30), 123 (100), 95 (46); FABMS
m/z 245 [M (37Cl) + Na]+ (7), 243 [M (35Cl) + Na]+ (20), 223 [M
(37Cl) + H]+ (3), 221 [M (35Cl) + H]+ (9), 178 [M (37Cl) - CH3CHO]+
(6), 176 [M (35Cl) - CH3CHO]+ (36), 156 (7), 154 (26); HRESIMS
m/z 243.0406 (calcd for C9H13ClO4Na, 243.0400).
Acknowledgment. This work was supported by a grant from Marine
Biotechnology Programs funded by Ministry of Land, Transport and
Maritime Affairs, Republic of Korea. Mass spectral data were kindly
provided by the Korea Basic Science Institute.
Chlorohydroaspyrone B (2): colorless oil; [R]2D0 +70 (c 0.1, CHCl3);
UV (MeOH-CHCl3, 9:1) λmax (log ε) 272 (4.40); IR (neat) νmax 3379,
1
2981, 1706, 1647, 1541, 1379, 1214, 1048 cm-1; H and 13C NMR
(DMSO-d6), see Table 1; 1H NMR (C6D6, 400 MHz) δ 6.43 (1H,
deformed-d, J ≈ 2.0 Hz, H-4), 3.47 (1H, ddd, J ) 8.6, 6.5, ∼2.0 Hz,
H-5), 3.89 (1H, dq, J ) 8.6, 6.5 Hz, H-6), 1.05 (3H, d, J ) 6.5 Hz,
H3-7), 4.34 (1H, dd, J ) 6.5, 5.9 Hz, H-8), 4.41 (1H, dq, J ) 6.5, 6.5
Hz, H-9), 1.36 (3H, d, J ) 6.5 Hz, H3-10), 3.26 (1H, d, J ) 6.5 Hz,
5-OH), 1.62 (1H, d, J ) 5.9 Hz, 8-OH); 13C NMR (C6D6, 100 MHz)
δ 164.1 (qC, C-2), 130.4 (qC, C-3), 146.3 (CH, C-4), 68.0 (CH, C-5),
79.2 (CH, C-6), 18.1(CH3, C-7), 75.9 (CH, C-8), 59.7 (CH, C-9), 20.1
(CH3, C-10); EIMS m/z 223 [M (37Cl) + 1]+ (0.3), 221 [M (35Cl) +
1]+ (0.6), 203 [(M + 1) - H2O]+ (0.6), 178 [M (37Cl) - CH3CHO]+
(9), 176 [M (35Cl) - CH3CHO]+ (29), 157 (100), 139 (57), 113 (84),
95 (40), 85 (70); HRESIMS m/z 243.0404 (calcd for C9H13ClO4Na,
243.0400).
Aspyrone (3), Asperlactone (4), and Penicillic Acid (5). Spectro-
scopic data were virtually identical to those reported in the literature.4,5
Treatment of Aspyrone (3) with 37% HCl and HPLC Analysis
of the Reaction Mixture. Hydrochloric acid (37%, 0.1 mL) was added
to a solution of aspyrone (3) (5.0 mg) (0.02 mmol) in CHCl3 (1.0 mL)
at 0 °C, and then the mixture was stirred for 30 min. The reaction
mixture was then poured into H2O and extracted with EtOAc. The
EtOAc extract was washed with brine, then dried over MgSO4. After
removal of the solvent under reduced pressure, the residue was divided
into two samples for purification of reaction product and HPLC analysis
(∼1 mg less). The former was purified by silica gel column chroma-
tography (n-hexane-EtOAc, 1:5), followed by HPLC (ODS, MeOH-
H2O, 2:3) to furnish chlorohydroaspyrone A (1, 2.0 mg) and its isomer,
Supporting Information Available: 1H and 13C NMR spectra of 1
and 2 in DMSO-d6 and of 2 in C6D6, H NMR spectrum of 1a (in
DMSO-d6), and comparison of HPLC chromatograms of the reaction
mixture with those of 1 and 2. These materials are available free of
1
References and Notes
(1) Blunt, J. W.; Copp, B. R.; Hu, W.-P.; Munro, M. H. G.; Northcote,
P. T.; Prinsep, M. R. Nat. Prod. Rep. 2007, 24, 31–86.
(2) Nguyen, H. P.; Zhang, D.; Lee, U.; Kang, J. S.; Choi, H. D.; Son, B. W.
J. Nat. Prod. 2007, 70, 1188–1190.
(3) Zhang, D.; Noviendri, D.; Nursid, M.; Yang, X.; Son, B. W. Nat. Prod.
Sci. 2007, 13, 251–254.
(4) Garson, M. J.; Staunton, J.; Jones, P. G. J. Chem. Soc., Perkin Trans.
1 1984, 1021–1026.
(5) Cole, R. J.; Cox, R. H. Handbook of Toxic Fungal Metabolites;
Academic Press: New York, 1981; pp 520-526.
(6) Namikoshi, M.; Negishi, R.; Nagai, H.; Dmitrenok, A.; Kobayashi, H.
J. Antibiot. 2003, 56, 755–761.
(7) Alkofahi, A.; Ma, W.-W.; McKenzie, A. T.; Byrn, S. R.; McLaughlin,
J. L. J. Nat. Prod. 1989, 52, 1371–1373.
(8) (a) Shing, T. K. M.; Tai, V. W.-F. J. Org. Chem. 1999, 64, 2140–
2144. (b) Matsumori, N.; Kaneno, D.; Murata, M.; Nakamura, H.;
Tachibana, K. J. Org. Chem. 1999, 64, 866–876.
(9) Abrell, L. M.; Borgeson, B.; Crews, P. Tetrahedron Lett. 1996, 37,
2331–2334.
NP800107C